Postpoliomyelitis Syndrome

Postpoliomyelitis syndrome is characterized by a sudden or progressive loss of muscle strength, muscle atrophy, muscle pain, fatigue, intolerance to cold, after a period of at least 15 years from the acute polio virus infection, a period of neurological and functional stability. Here is the latest research.

September 16, 2021
Open Access

Early effects of the COVID-19 pandemic on the acute flaccid paralysis surveillance in East and Southern African countries.

The Pan African Medical Journal
Daudi ManyangaFussum Daniel
September 16, 2021

Acceptance Rates and Beliefs toward COVID-19 Vaccination among the General Population of Pakistan: A Cross-Sectional Survey.

The American Journal of Tropical Medicine and Hygiene
Farah YasminMuhammad Samsoor Zarak
September 16, 2021

Public Finance of Universal Routine Childhood Immunization in India: District Level Cost Estimates.

Health Policy and Planning
Emily SchuellerRamanan Laxminarayan
September 11, 2021

[Post-polio Syndrome in the Perioperative Phase].

Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
David GebauerAndreas Sandner-Kiesling
September 6, 2021
Open Access

Description of non-polio enteroviruses identified in two national surveillance programmes in South Africa.

Southern African Journal of Infectious Diseases
Wayne HowardAdrian J Puren
September 6, 2021
Review
Open Access

Frontotemporal Pathology in Motor Neuron Disease Phenotypes: Insights From Neuroimaging.

Frontiers in Neurology
Mary Clare McKennaPeter Bede
September 6, 2021

Real-time prediction model of cVDPV2 outbreaks to aid outbreak response vaccination strategies.

Vaccine
Arend VoormanSamuel Okiror
September 4, 2021

Can Tho Transfer Technique: Extensor Hallucis Longus to Tibialis Anterior Tenodesis for Footdrop.

Journal of the American Podiatric Medical Association
Ezequiel PalmanovichBruce Lehnert
September 3, 2021

Cost-Minimization and Budget Impact Analysis of a Hexavalent Vaccine (Hexaxim®) in the Colombian Expanded Program on Immunization.

Value in Health Regional Issues
Martín RomeroJuan-Guillermo Lopez
September 2, 2021

Toward Establishing Integrated, Comprehensive, and Sustainable Meningitis Surveillance in Africa to Better Inform Vaccination Strategies.

The Journal of Infectious Diseases
Brenda Anna Kwambana-AdamsJason Mathiu Mwenda
September 1, 2021

A retrospective study of the impact of health worker strikes on maternal and child health care utilization in western Kenya.

BMC Health Services Research
Michael L ScanlonAstrid Christoffersen-Deb
September 1, 2021

An algorithmic approach to total hip arthroplasty in patient with post-polio paralysis and fixed pelvic obliquity.

Bone & Joint Open
Rajesh MalhotraKrishna K Eachempati
September 1, 2021
Preprint
Open Access

VaxArray Immunoassay for the Multiplexed Quantification of Poliovirus D-Antigen

BioRxiv : the Preprint Server for Biology
Erica D DawsonK. L. Rowlen
August 31, 2021
Review
Open Access

Vaccine Development Throughout History.

Curēus
Amr SalehRahul Kashyap
August 31, 2021

Vaccination programs for pregnant women in Europe, 2021.

Vaccine
Helena C MaltezouAlexandros Rodolakis

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/postpoliomyelitis-syndrome/2ea118b7-7ce2-4613-a09e-d2f601a3a256